Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience

BACKGROUND: Data on the treatment of palmoplantar psoriasis (PP) are scarce, representing a therapeutic challenge. This study aims to assess the efficacy and safety of risankizumab in a population of patients with psoriasis with a palmoplantar involvement, over a 52-week treatment period. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldarola, Giacomo, Zangrilli, Arianna, Palmisano, Gerardo, Bavetta, Mauro, Moretta, Gaia, Pagnanelli, Gianluca, Panasiti, Vincenzo, Bianchi, Luca, De Simone, Clara, Peris, Ketty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108662/
https://www.ncbi.nlm.nih.gov/pubmed/37077769
http://dx.doi.org/10.7573/dic.2023-1-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108662/
https://www.ncbi.nlm.nih.gov/pubmed/37077769
http://dx.doi.org/10.7573/dic.2023-1-8

Ejemplares similares